Showing results (71-80 of 159) with videos related to
Sort By:
Pageof 16
Arteriosclerosis, Thrombosis, and Vascular Biology|November 18, 2006
Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonistDennis L Sprecher, Christine Massien, Greg Pearce, et al.Molecular Endocrinology (Baltimore, Md.)|November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonistBarry G Shearer, David J Steger, James M Way, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
Liver X receptor agonists increase airway reactivity in a model of asthma via increasing airway smooth muscle growthMark A Birrell, Jorge De Alba, Matthew C Catley, et al.The Journal of Investigative Dermatology|January 25, 2003
Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine productionAshley J Fowler, Mary Y Sheu, Matthias Schmuth, et al.Bioorganic & Medicinal Chemistry Letters|November 26, 2005
Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgammaEsther Y H Chao, Jon L Collins, Stéphanie Gaillard, et al.Biorxiv : the Preprint Server for Biology|May 18, 2026
Linking the kinetic mechanism to structural dynamics required for nucleotide hydrolysis by an alphavirus nsP2 RNA helicaseKacey M Talbot, Yuan-Wei Norman Su, Jake B Royster, et al.Molecular Endocrinology (Baltimore, Md.)|August 2, 2008
Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitmentCaroline A Phelan, Joseph M Weaver, David J Steger, et al.Journal of Medicinal Chemistry|April 29, 2005
Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRbeta and ERRgammaWilliam J Zuercher, Stéphanie Gaillard, Lisa A Orband-Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivoAndrew E Place, Nanjoo Suh, Charlotte R Williams, et al.Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of a novel class of PPARdelta partial agonistsBarry G Shearer, Hari S Patel, Andrew N Billin, et al.Pageof 16